Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2019 Oct 25;26(3):472–479. doi: 10.1016/j.bbmt.2019.10.017

Table 2.

Characteristics of Post-Transplantation TKI Maintenance

Variable Value
Number of patients receiving maintenance TKI therapy 89
Number of TKI maintenance therapies, n (%)
 1 77 (87)
 >1 12 (13)
Same TKI given pre-HCT and post-HCT, n (%)
 No 72 (81)
 Yes 17 (19)
TKIs used as maintenance therapy, n
 Dasatinib 50
 Imatinib 27
 Nilotinib 27